[1]
Bodla, M.A. et al. 2026. Comparison of Efficacy of Intravitreal Ranibizumab and Aflibercept in Central Serous Chorioretinopathy. Journal of Clinical and Community Ophthalmology. 4, 02 (Jul. 2026). DOI:https://doi.org/10.71177/jcco.v4i02.114.